Pharmaceutical Published Insights

Published Date : 30 Apr, 2026

The Global Aldosterone Synthase Inhibitors Market is estimated to be valued at USD 248.4 Mn in 2026 and is expected to reach USD 723.4 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 16... View more

Published Date : 30 Apr, 2026

The Global Neulasta Market is estimated to be valued at USD 210.3 million in 2026 and is expected to reach USD 95.3 million by 2033, exhibiting a compound annual growth rate (CAGR) of -10.7% from 2026 to 2033. The Global Neulasta Market, a key segment within the biote... View more

Published Date : 30 Apr, 2026

The Global XARELTO Market is estimated to be valued at USD 3.11 Bn in 2026 and is expected to decline to USD 1.77 Bn by 2033, reflecting a negative compound annual growth rate (CAGR) of -7.8% from 2026 to 2033. While ... View more

Published Date : 30 Apr, 2026

The Global Lantus Market is estimated to be valued at USD 2.24 Bn in 2026 and is expected to reach USD 3.37 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.0% from 2026 to 2033. ... View more

Published Date : 30 Apr, 2026

The Global Humira Market is estimated to be valued at USD 4.68 Bn in 2026 and is expected to reach USD 1.20 Bn by 2033, declining at a compound annual growth rate (CAGR) of -17.6% from 2026 to 2033. ... View more

Published Date : 30 Apr, 2026

The global Rituxan market, valued at USD 1,584.3 Mn in 2026, is expected to decline steadily to USD 1,082.1 Mn by 2033, exhibiting a negative compound annual growth rate (CAGR) of -5.3% from 2026 to 2... View more

Published Date : 30 Apr, 2026

The Global Eylea Market is estimated to be valued at USD 838.6 Mn in 2026 and is expected to reach USD 673.7 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of -3.1% from 2026 to 2033. ... View more

Published Date : 30 Apr, 2026

The Global Lucentis Market is estimated to be valued at USD 739.1 Mn in 2026 and is expected to reach USD 64.1 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of -29.5% from 2026 to 2033. The global Lucent... View more

Published Date : 30 Apr, 2026

The Global Remicade Market is estimated to be valued at USD 1,422.0 Mn in 2026 and is expected to reach USD 655.0 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of -10.48% from 2026 to 2033. Despite the prevalence of autoimmune diseases such as rheumatoid... View more

Published Date : 30 Apr, 2026

The Global Loperamide Hydrochloride Market is estimated to be valued at USD 3.73 bn in 2026 and is expected to reach USD 5.59 bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.0% from 2026 to 2033. The global loperamide... View more

Published Date : 30 Apr, 2026

The Global Eye Drops Market is estimated to be valued at USD 7.11 Bn in 2026 and is expected to reach USD 9.61 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 4.4% from 2026 to 2033. The global eye drop... View more

Published Date : 30 Apr, 2026

The Global Melatonin Sleep Gummy Market is estimated to be valued at USD 396.8 Mn in 2026 and is expected to reach USD 707.0 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2026 to 2033. The g... View more

Published Date : 30 Apr, 2026

The global Neupogen market, while initially experiencing growth, is now facing a decline due to several factors. Neupogen (filgrastim) is a recombinant human granulocyte colony-stimulating factor (G-CSF) that stimulates the production of neutrophils, which are essenti... View more

Published Date : 30 Apr, 2026

The Global Xgeva Market is estimated to be valued at USD 2,501.1 Million in 2026 and is expected to reach USD 2,856.0 Million by 2033, exhibiting a compound annual growth rate (CAGR) of 2.9% from 2026 to 2033. The global Xgeva market represents a critical segment with... View more

Published Date : 30 Apr, 2026

The global hereditary spastic paraplegia market is estimated to be valued at USD Mn 194.8 Mn in 2026 and is expected to reach USD Mn 321.1 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 7.4% from 2026 ... View more

Published Date : 30 Apr, 2026

The Global Polidocanol Injection Market is estimated to be valued at USD 99.9 million in 2026 and is expected to reach USD 169.1 million by 2033, exhibiting a compound annual growth rate (CAGR) of 7.8% from 2026 to 2033. The global po... View more

Published Date : 30 Apr, 2026

The Global Liraglutide Market is estimated to be valued at USD 2.38 Bn in 2026 and is expected to decline to USD 1.58 Bn by 2033, exhibiting a negative compound annual growth rate (CAGR) of -5.6% from 2026 to 2033.... View more

Published Date : 30 Apr, 2026

The Global Topical Analgesic Market is estimated to be valued at USD 12.89 Bn in 2026 and is expected to reach USD 20.03 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033. The globa... View more